Reference number : 236-2011-2012-Q1-00796, amendment number : , agreement type : G, recipient legal name : BUSCHMANN, Michael D, recipient country : CA, recipient province : QC, recipient city : Montréal, recipient postal code : H3T 1J4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 521739.0, agreement start date : 2011-10-01, agreement end date : 2014-09-30, description english : Gene Delivery of Glucagon-like Peptide-1 (GLP-1) for the Treatment of Type 2 Diabetes, description french : Gene Delivery of Glucagon-like Peptide-1 (GLP-1) for the Treatment of Type 2 Diabetes, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2011-12 to 2014-15), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2011-12 à 2014-15), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada